BRIEF-Alvotech SA MHRA Accepts Marketing Application For AVT23 Biosimilar To Xolair

Reuters
26 Mar
BRIEF-<a href="https://laohu8.com/S/ALVO">Alvotech</a> SA MHRA Accepts Marketing Application For AVT23 Biosimilar To Xolair

March 26 (Reuters) - Alvotech SA ALVO.O:

  • ALVOTECH SA - MHRA ACCEPTS MARKETING APPLICATION FOR AVT23 BIOSIMILAR TO XOLAIR

Source text: ID:nGNX2JMGK1

Further company coverage: ALVO.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10